CPC-M: Innovative in the fight against lung diseases

Our lungs provide us with oxygen, enabling us to breathe and thus live. Patients with chronic lung disease suffer a high symptom burden and a diminished quality of life. Their breathing is impaired, they have trouble getting air in and out of the lungs, and in the worst case scenario, the lungs collapse. COPD, asthma, lung cancer and lung fibrosis are therefore the focus of the scientists and physicians at the Comprehensive Pneumology Center in Munich. We want to achieve a better understanding of lung diseases and develop new diagnostic options and therapies. Therefore we are pursuing an interdisciplinary, translational approach, also known as "bench to bedside". This means that our basic research should lead as quickly and effectively as possible to better treatment for patients. Many chronic diseases of the lungs are still considered incurable.

 

About usPartner

Our Research Projects

Calcium channels in signaling pathways

Can channel modulators affect lung diseases?

[Translate to Englisch:] Calciumkanäle in Signalwegen der Lunge, Link zum Projekt

Enigma collagen synthesis

Which protein prevents scarring of lung tissue?

[Translate to Englisch:] Lungenfibrose verhindern, Link zum Projekt

Patient management in COPD

Study focusing on quality of life and treatment

[Translate to Englisch:] COPD Patientenmanagement, Link zum Projekt

Transplantations in lung failure

Do stem cells help rebuild lung tissue?

Atlas of the aging lung

What happens in lung cells as they get older?

Ventilation of premature babies

How do we recognize and prevent chronic lung damage?

[Translate to Englisch:] Lungenschäden bei Frühgeborenen, Link zum Projekt

Common disease COPD

Two promising therapeutic approaches against COPD

[Translate to Englisch:] COPD als Volkskrankheit, Link zum Projekt

Asthma in children and adolescents

ALLIANCE study provides Germany-wide overview of disease forms

[Translate to Englisch:] Asthma bei Kindern, Link zum Projekt

Interstitial Lung Diseases

Clinical studies: How to slow down the progression of the diseases?